EUVIMEDEUVIMED entdecken
Crossref

Investigation of derivatives of 2H-chromene oximes as anticancer agents

Vijayabhaskar Bandaru, Ganesh Latambale, Lalan Kumar, Jyothi Dhuguru, K Sunanda Kumari, Vinod Jadhav, Kapil Juvale, Siddaiah Vidavalur

Annales Pharmaceutiques Françaises · 2025

DOI: 10.1016/j.pharma.2025.11.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2025. Verfasst von Vijayabhaskar Bandaru und 7 weiteren Autor:innen. Beteiligte Einrichtung: Aragen life sciences, 500075 Hyderabad, India. Hauptthemen laut MEDLINE: Antineoplastic Agents, Oximes, Benzopyrans. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chromene derivatives are widely recognised for their broad range of biological activities, especially their strong potential in fighting cancer. In this work, we developed novel oxime-based chromene derivatives as potential anticancer agents. A total of 14 novel oxime derivatives were designed, synthesized, and screened for their antiproliferative effect against a panel of cell lines, which included A549 (lung carcinoma) and MDA-MB-231 and MCF-7 (breast cancer) cell lines, for their anti-cancer activity. Among the synthesised compounds, 6i and 6j were found to be most promising, with 6i showing an antiproliferative effect against A549 and MCF-7 cells while 6j was selective toward MCF-7 cells. None of the compounds was found to be toxic against non-cancer NIH-3T3 cells. Finally, we used an in-silico approach to predict the drug-likeness and pharmacokinetic properties, wherein all the compounds were found to follow drug-likeness parameters and showed optimum pharmacokinetic properties. This study could be a stepping stone for further optimisation of chromene-based oximes for their anticancer activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsOximesBenzopyransHumansMiceAnimalsCell Line, TumorDrug Screening Assays, AntitumorCell ProliferationMCF-7 CellsNIH 3T3 CellsA549 Cells

Stichwörter der Autor:innen

2H-Chromenes2H-chromènesBreast cancerCancer du poumonCancer du seinChalconesLung cancerOximes

Substanzen

Antineoplastic AgentsOximesBenzopyrans

Autor:innen und Institutionen

  • Aragen life sciences, 500075 Hyderabad, India.
  • School of Pharmacy and Technology SVKM's NMIMS, Bada Bangarda, 452005 Indore, Madhya Pradesh India; Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, 400056 Vile Parle…
  • Department of Chemistry, CDRI, Lucknow, 226031 Lucknow, India.
  • Department of Microbiology & FST, GITAM University, 530003 Visakhapatnam, India.
  • Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, 400056 Vile Parle (W), Mumbai India. Electronic address: kjuvale@gmail.com.
  • Department of Chemistry, Andhra University, 530003 Visakhapatnam, India. Electronic address: sidduchem@gmail.com.

Zitieren

APA

Bandaru, V., Latambale, G., Kumar, L., Dhuguru, J., Kumari, K. S., Jadhav, V., Juvale, K., & Vidavalur, S. (2025). Investigation of derivatives of 2H-chromene oximes as anticancer agents. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2025.11.004

Vancouver

Bandaru V, Latambale G, Kumar L, Dhuguru J, Kumari KS, Jadhav V, et al. Investigation of derivatives of 2H-chromene oximes as anticancer agents. Annales Pharmaceutiques Françaises. 2025. doi:10.1016/j.pharma.2025.11.004

BibTeX
@article{Bandaru2025,
  author = {Bandaru, Vijayabhaskar and Latambale, Ganesh and Kumar, Lalan and Dhuguru, Jyothi and Kumari, K Sunanda and Jadhav, Vinod and Juvale, Kapil and Vidavalur, Siddaiah},
  title = {Investigation of derivatives of 2H-chromene oximes as anticancer agents},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2025},
  doi = {10.1016/j.pharma.2025.11.004}
}
Kostenlos starten →